Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
The Lancet. Haematology|February 5, 2025
Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNetVincent Ribrag, Dominique Bron, Grzegorz Rymkiewicz, et al.
The Lancet. Haematology|December 22, 2015
Combination of romidepsin with cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated patients with peripheral T-cell lymphoma: a non-randomised, phase 1b/2 studyJehan Dupuis, Franck Morschhauser, Hervé Ghesquières, et al.
Leukemia & Lymphoma|August 17, 2022
Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II studyAspasia Stamatoullas, Hervé Ghesquières, Pierre Feugier, et al.
Blood Advances|October 7, 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnosticAurélie Montagne, Gildas Bertho, Thomas Papastergiou, et al.
Journal of Crohn'S & Colitis|October 3, 2017
Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological EntitiesClélia Coutzac, Julien Adam, Emilie Soularue, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2017
Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)Frédéric Bigot, Eduardo Castanon, Capucine Baldini, et al.
Bone Marrow Transplantation|February 12, 2022
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective studyDomitille Costes-Tertrais, Thomas Hueso, Thomas Gastinne, et al.
Leukemia & Lymphoma|November 18, 2022
Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 studyJohn Kuruvilla, Philippe Armand, Mehdi Hamadani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2018
Long-Term Survival in Patients Responding to Anti-PD-1/PD-L1 Therapy and Disease Outcome upon Treatment DiscontinuationMarie-Léa Gauci, Emilie Lanoy, Stéphane Champiat, et al.
Blood|April 1, 2004
Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trialNicole Casadevall, Pierre Durieux, Stéphanie Dubois, et al.
Pageof 21